Coca-Cola Içecek Anonim Sirketi (IST:CCOLA)

CTI BioPharma Income Statement

Financials in millions TRY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	134,862	137,683	145,884	93,190	21,930	14,391
Revenue Growth (YoY)	-16.30%	-5.62%	56.55%	324.95%	52.38%	19.85%
Cost of Revenue	90,352	89,771	98,780	65,086	14,295	9,379
Gross Profit	44,511	47,912	47,104	28,104	7,635	5,012
Selling, General & Admin	29,698	29,288	26,374	15,954	4,140	2,816
Other Operating Expenses	-690.92	-495.8	271.62	345.72	-17.38	18.6
Operating Expenses	29,007	28,792	26,646	16,300	4,123	2,835
Operating Income	15,504	19,119	20,458	11,804	3,512	2,177
Interest Expense	-10,050	-9,593	-6,392	-3,155	-549.43	-371.36
Interest & Investment Income	1,865	1,942	1,682	934.93	352.68	166.26
Earnings From Equity Investments	6.25	-4.79	-24.32	-5.19	-3.67	-3.36
Currency Exchange Gain (Loss)	-1,128	-757.71	-1,410	-497.69	609.99	-81.82
Other Non Operating Income (Expenses)	6,556	9,288	23,398	9,926	-79.5	-26.04
EBT Excluding Unusual Items	12,753	19,994	37,711	19,008	3,842	1,861
Gain (Loss) on Sale of Investments	-188.68	-176.31	-311.96	-13.98	-278.46	-101.39
Pretax Income	12,725	19,942	37,475	19,003	3,572	1,766
Income Tax Expense	2,694	5,051	6,924	4,616	1,151	447.98
Earnings From Continuing Operations	10,032	14,891	30,551	14,387	2,421	1,318
Earnings From Discontinued Operations	-	-	-	-	-	-3.96
Net Income to Company	10,032	14,891	30,551	14,387	2,421	1,314
Minority Interest in Earnings	-94.89	-78.12	-838.45	-510.5	-149.43	-81.54
Net Income	9,937	14,813	29,713	13,877	2,271	1,233
Net Income to Common	9,937	14,813	29,713	13,877	2,271	1,233
Net Income Growth	-69.27%	-50.14%	114.12%	510.93%	84.27%	27.64%
Shares Outstanding (Basic)	2,798	2,798	2,798	2,798	2,798	2,798
Shares Outstanding (Diluted)	2,798	2,798	2,798	2,798	2,798	2,798
EPS (Basic)	3.55	5.29	10.62	4.96	0.81	0.44
EPS (Diluted)	3.55	5.29	10.62	4.96	0.81	0.44
EPS Growth	-69.27%	-50.14%	114.12%	510.93%	84.27%	27.64%
Free Cash Flow	4,019	5,090	9,981	1,666	2,757	2,314
Free Cash Flow Per Share	1.44	1.82	3.57	0.59	0.98	0.83
Dividend Per Share	1.072	1.072	0.715	0.268	0.214	0.255
Dividend Growth	50.00%	50.00%	166.72%	24.94%	-15.72%	182.78%
Gross Margin	33.01%	34.80%	32.29%	30.16%	34.81%	34.83%
Operating Margin	11.50%	13.89%	14.02%	12.67%	16.01%	15.13%
Profit Margin	7.37%	10.76%	20.37%	14.89%	10.36%	8.57%
Free Cash Flow Margin	2.98%	3.70%	6.84%	1.79%	12.57%	16.08%
EBITDA	21,092	24,665	25,781	15,619	4,541	3,029
EBITDA Margin	15.64%	17.91%	17.67%	16.76%	20.71%	21.05%
D&A For EBITDA	5,588	5,546	5,324	3,815	1,030	851.63
EBIT	15,504	19,119	20,458	11,804	3,512	2,177
EBIT Margin	11.50%	13.89%	14.02%	12.67%	16.01%	15.13%
Effective Tax Rate	21.17%	25.33%	18.48%	24.29%	32.23%	25.36%

Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.